hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Product
RxNorm concept 1164652, clinical dose form group (scdg).
- RxCUI
- 1164652
- Term type
- Clinical dose form group (SCDG)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1164652 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- methenamine (IN, has ingredient)
- methylene blue (IN, has ingredient)
- phenyl salicylate (IN, has ingredient)
- hyoscyamine (IN, has ingredient)
- sodium phosphate, monobasic (IN, has ingredient)
- Phosphasal Oral Product (SBDG, has tradename)
- Urelle Oral Product (SBDG, has tradename)
- Uretron DS Oral Product (SBDG, has tradename)
- Uribel Oral Product (SBDG, has tradename)
- Ustell Oral Product (SBDG, has tradename)
- Urimar Reformulated Oct 2013 Oral Product (SBDG, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1164652 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1164652 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1164652. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.